Update: Bivalent COVID-19 vaccine dose for children age 6 months - 4 years old
Author: Caregiver Communications/Tuesday, December 13, 2022/Categories: News, News, News (CCF), COVID-19 News
In December, the U.S. Food and Drug Administration authorized the use of the updated bivalent COVID-19 vaccines manufactured by Pfizer and Moderna in children from 6 months to 4 years of age. This updated vaccine is expected to provide better protection against currently circulating strains of COVID-19.
Three-dose primary series information
Children aged 6 months through 4 years who have not started their three-dose primary series of the Pfizer vaccine OR have not yet received their third dose will now receive the bivalent Pfizer vaccine as their third dose. Their first two doses will be the original monovalent COVID-19 vaccine.
Children aged 6 months through 4 years who have already received all three doses of their primary series are NOT currently eligible for a bivalent booster dose.
What if my child received the Moderna COVID-19 vaccine?
Children aged 6 months through 4 years who received the original Moderna COVID-19 vaccine ARE eligible for a single booster dose of the Moderna bivalent vaccine two months after completing their primary series with the original Moderna COVID-19 vaccine.
Cleveland Clinic is currently ranked as one of the nation’s top hospitals by U.S. News & World Report (2022-2023). Visit us online at http://www.clevelandclinic.org for a complete listing of our services, staff and locations.